Centre Hospitalier Victor Dupouy
5
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
20.0%
1 terminated/withdrawn out of 5 trials
75.0%
-11.5% vs industry average
20%
1 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Qualitative Evaluation of Therapeutic Alliance in Adolescent Psychiatry
Role: lead
Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia
Role: collaborator
Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:
Role: collaborator
Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia
Role: collaborator
Clinical Evaluation of AutoFlow Mode During Mechanical Ventilation
Role: lead
All 5 trials loaded